relcovaptan has been researched along with Acquired Nephrogenic Diabetes Insipidus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthus, MF; Bernier, V; Bichet, DG; Bouvier, M; Brouard, R; Debrand, N; Laperrière, A; Lonergan, M; Morello, JP; Salahpour, A; Zarruk, A | 1 |
| Deen, PM; Knoers, NV; Robben, JH; Sze, M | 1 |
2 other study(ies) available for relcovaptan and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cells, Cultured; Chromosomes, Human, X; Diabetes Insipidus, Nephrogenic; Genetic Linkage; Humans; Indoles; Male; Mutation; Pyrrolidines; Receptors, Vasopressin | 2006 |
Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antigens, Surface; Binding, Competitive; Blotting, Western; Cell Line; Cell Membrane; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Dogs; Electrophoresis, Polyacrylamide Gel; Green Fluorescent Proteins; Immunohistochemistry; Indoles; Kidney; Molecular Chaperones; Morpholines; Mutation; Pyrrolidines; Receptors, Vasopressin; Spiro Compounds; Transfection | 2007 |